OverviewChartNewsTraderScreen

Infant Bacterial Therapeutics AB .../  SE0008015259  /

OMX Nordic
24/05/2024  00:00:00 Chg. -3.40 Volume Bid17:29:40 Ask17:29:40 High Low
91.20SEK -3.59% 5,453
Turnover: 504,324.80		 87.40Bid Size: - 92.00Ask Size: - 93.80 91.20
GlobeNewswire 31/01/2019 Gastrointestinal Diseases Pipeline Review, 2018 - Which Companies are the Most Active within Each Pi...
GlobeNewswire 12/04/2018 Infant Bacterial Therapeutics publishes Annual Report for 2017
GlobeNewswire 28/02/2018 Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - December 31, 2017
GlobeNewswire 02/02/2018 Outcome of Infant Bacterial Therapeutics' rights issue
GlobeNewswire 10/01/2018 Prospectus relating to Infant Bacterial Therapeutics' rights issue published
GlobeNewswire 08/01/2018 Extraordinary general meeting in Infant Bacterial Therapeutics
GlobeNewswire 11/12/2017 Infant Bacterial Therapeutics presents data from its Safety and Tolerability Study in premature infa...
GlobeNewswire 24/11/2017 Notice of extraordinary general meeting in Infant Bacterial Therapeutics
GlobeNewswire 24/11/2017 Infant Bacterial Therapeutics announces capital raise of approximately SEK 545 million in total
GlobeNewswire 23/11/2017 Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - September 29, 2017
GlobeNewswire 08/11/2017 Infant Bacterial Therapeutics AB (publ) announces that the Nomination Committee is appointed for the...
GlobeNewswire 28/09/2017 European Medicines Agency adopts a positive opinion on the Paediatric Investigation Plan for IBT's l...
GlobeNewswire 11/09/2017 Infant Bacterial Therapeutics announces that top line data demonstrate similar safety and tolerabili...
GlobeNewswire 08/09/2017 Information from Infant Bacterial Therapeutics Capital Markets Day 2017
GlobeNewswire 28/08/2017 Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - June 30, 2017
GlobeNewswire 04/05/2017 Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - March 31, 2017
GlobeNewswire 06/04/2017 Infant Bacterial Therapeutics AB (publ) Annual Report for 2016 has now been published
GlobeNewswire 05/04/2017 Annual General Meeting in Infant Bacterial Therapeutics AB
GlobeNewswire 10/03/2017 Infant Bacterial Therapeutics AB (publ), (IBT) has been approved for listing on Nasdaq First North's...
GlobeNewswire 01/03/2017 IBT to present at Bio-Europe Spring 2017
GlobeNewswire 14/02/2017 Infant Bacterial Therapeutics AB (publ), (IBT) Interim report January 1 - December 31 2016
GlobeNewswire 24/01/2017 Last patient enrolled in IBT's Phase 2 study
GlobeNewswire 15/12/2016 IBT to present at 9th Annual Biotech Showcase 2017
GlobeNewswire 14/12/2016 IBT adds new indication for Gastroschisis-Related Intestinal Dysfunction